ADMA BIOLOGICS, INC. (ADMA) News Headlines

▮ More

Date

Headline

2/12/2019 9:09:45 PM 5 Top Gainers In Healthcare Sector (CASM, VKTX, ADMA...)

1/7/2019 7:20:55 AM ADMA Biologics Submits Response And Provides Supplemental Information To FDA For BIVIGAM CRL

12/20/2018 12:39:57 AM 7 Stocks That Made Big Moves After-hours (TLRY, SPPI, ADMA, DBVT...)

12/17/2018 7:02:43 AM WBB Securities Starts ADMA BIOLOGICS, INC. (ADMA) At Speculative Buy With $9 Price Target

11/26/2018 12:56:25 AM Biotech Stocks Facing FDA Decision In December

10/17/2018 7:09:20 AM ADMA Biologics Receives PDUFA Date Of April 2, 2019 For RI-002

10/12/2018 2:02:47 AM IMDZ Discontinues SYNOVATE, FDA Delays Decision On ADMA's Bivigam, TRVN Snubbed

10/11/2018 8:49:31 AM ADMA Biologics Provides Regulatory Update For BIVIGAM

10/3/2018 7:12:29 AM ADMA BioCenters Gets FDA Approval For Third Plasma Collection Center

10/1/2018 7:09:15 AM ADMA Biologics Resubmits BLA For RI-002

9/28/2018 5:42:28 AM Biotech Stocks Facing FDA Decision In October

9/5/2018 8:11:30 AM LabConnect Appoints Eric Richman As Chairman

9/5/2018 7:09:03 AM ADMA Biologics Reports FDA Inspection Database Confirms VAI Status Of Boca Raton, FL Facility

8/10/2018 7:10:01 AM ADMA Biologics Q2 Net Loss $14.7 Mln Or $0.35/Shr Vs Loss Of $9.0 Mln Or $0.55/Shr Last Year

7/26/2018 7:59:48 AM ADMA Biologics Gets PDUFA Date For BIVIGAM Regulatory Submission; Target Action Date For PAS Is Oct. 25, 2018

6/12/2018 4:08:52 PM ADMA Biologics Closes $40 Mln Public Offering

6/8/2018 9:10:01 AM ADMA Biologics Prices Public Offering Of 8.37 Mln Shares At $4.78/Shr

6/7/2018 4:11:33 PM ADMA Biologics Announces Proposed Public Offering Of Common Stock

5/16/2018 7:32:20 AM ADMA Biologics Granted U.S. Patent For Treating Respiratory Infections

5/15/2018 2:13:26 AM ADMA Braces For Busy Year, AMPH Gets FDA Nod, CHRS Faces Litmus Test In Nov.

Adma Biologics, Inc. (ADMA)